Task: Answer Verification
Input (English): Question: Is the aryl hydrocarbon receptor constitutively active in advanced prostate cancer cells?
Answer: Together, these results show that AhR is constitutively active in advanced prostate cancer cell lines that model hormone refractory prostate cancer. Chemical ablation of AhR signaling can reduce the growth of advanced prostate cancer cells, an effect not achieved with androgen receptor inhibitors or growth in androgen depleted media.
Output (English): yes